entertainment -WSS

entertainment

author：Wikipedia 2025-09-29 12:30:03 - browse：9

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of expert advisers to the Food and Drug Administration on Friday voted in favor of expanding the use of CAR-T therapy in blood cancer, despite concerns about the powerful treatment’s side effects.

The group voted 11-0 that the benefits of Carvykti, a CAR-T medicine from Johnson & Johnson and Legend Biotech, outweighed its risk for patients with multiple myeloma whose disease has persisted despite initial treatment. The same panel voted 8-3 in favor of Abecma, from Bristol Myers Squibb and 2seventy Bio, for multiple myeloma patients who’ve received at least two lines of therapy. Currently both medicines are approved only for patients who have been treated for myeloma with four or more medications.

In clinical trials, each drug proved to significantly delay disease progression compared to standard therapy. But zooming in on the data, the FDA observed an alarming imbalance of deaths in the early months of both studies, finding that more patients in the CAR-T group died of myeloma or side effects than those receiving the standard of care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： The untold story of TV’s first prescription drug ad

WSS

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

Doctors increasingly discourage vaping amid mounting health concerns

Doctors increasingly discourage vaping amid mounting health concerns

He's 19 months old and has one of the world’s rarest diseases

Adidas to release second batch of Yeezy sneakers after breakup with Ye

Doctors in states that ban abortion can still help patients

hotspot

entertainment

knowledge

Peter Hotez and the public health issue of online harassment

Stem cell biologist probes earliest stages of human development

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Harvard's David Sinclair gets blowback over aging

FDA approval of Sarepta Duchenne genetic therapy gives me hope

HCA says smaller share of spending going to labor

Wildfire smoke exposes gaps in outdoor worker protections

Biden's 'march

In age of alternative facts, a scholarly course on calling out crap

Ozempic has benefits for kidney disease as well as diabetes

entertainment

Readout Newsletter: BridgeBio, Akero, and human embryo models

Change Healthcare: What is it, why does its cyberattack matter?

Streamlined flu vaccines recommended by FDA advisory panel

Readout Newsletter: BridgeBio, Akero, and human embryo models

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Doctors increasingly discourage vaping amid mounting health concerns

Wikipedia

hotspot

Wikipedia

entertainment